Market Overview:
The global shrimp disease diagnostic market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market is segmented by type, application, and region. The type segment is further divided into WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus), HPV (Hepatopancreatic Parvovirus), MBV (Monodon Baculovirus), IMNV(Infectious Myonecrosis virus) and NHP-B Necrotising hepatopancreatitis bacteria). The application segment is divided into fisheries, aquaculture laboratories, marine laboratories, education and research institutes, and others. Region wise the market is divided into North America, Latin America Europe Asia Pacific Middle East & Africa. The growth of the global shrimp disease diagnostic market can be attributed to factors such as rising demand for seafood products due to changing dietary preferences of consumers coupled with increasing awareness about the health benefits of consuming seafood products; growing prevalence of diseases in shrimps; increasing investments by private players in R&D activities for development of novel diagnostics for shrimp diseases; and expanding aquaculture sector globally.
Product Definition:
Shrimps Disease Diagnostic is a method or tool used to identify and diagnose shrimp diseases. It is important for commercial shrimp farmers to be able to accurately identify and diagnose diseases in their shrimp ponds, as this can help them take the necessary steps to treat and prevent outbreaks.
WSSV (White Spot Syndrome Virus):
White spot syndrome virus (WSSV) is a single-stranded DNA (ssDNA)-based virus. It causes white spot disease in crustaceans, such as shrimp and crabs. The disease is characterized by the appearance of small, roundish spots on the carapace of infected crustaceans. These spots are usually located in clusters and they may coalesce to form larger lesions with an umbilical cord-like appearance at the center.
TSV (Taura Syndrome Virus):
TSV (Taura Syndrome Virus) is a single-stranded DNA virus that belongs to the family of Herpesvirus. TSV causes shrimp disease, also known as shrimplike symptoms or disease (SDS), which includes decreased swimming speed, abnormal walking behavior and crawing, head pressing against the aquarium glass in an attempt to get out of water, loss of appetite and eventually death if not treated.
Application Insights:
Aquaculture laboratories held the largest share of the global shrimp disease diagnostic market in 2017. This is owing to a large number of aquafarming activities in Asia Pacific and Africa, which contribute significantly to overall revenue generation. In addition, presence of key manufacturers such as Merck Millipore Corporation and Thermo Fisher Scientific Inc., which offer advanced products for diagnosis aids growth further.
The EMS segment is expected to grow at fastest rate during forecast period due to rising incidences of infectious diseases among crustaceans worldwide. The major factors contributing towards high growth are increasing marine pollution along with overfishing & harvesting methods that damage sea grasses & coral reefs causing EMS in shrimps and other species including crabs, lobsters & octopus. Overharvesting has caused depletion in natural resources leading towards increase incidence rates globally resulting into lucrative business opportunities for market players during forecast period (2018-2030).
Regional Analysis:
North America dominated the global shrimp disease diagnostic market in 2017. This can be attributed to the presence of a large number of aquaculture facilities, increase in consumption of seafood, and rising awareness among people pertaining to food safety & hygiene. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing awareness regarding diseases prevalent in this region coupled with rapid urbanization and industrialization leading to unhealthy lifestyle changes. Moreover, government initiatives for improving water quality are anticipated favorably impact industry growth over the forecast period.
The European market is also estimated have significant potential due its high prevalence rate towards IMNV along with other factors such as change in climate conditions (hotter summers & colder winters), rise in demand for white spot shrimps from China & Japan which results into spread of infectious diseases within Europe's marine ecosystem thus hampering overall production levels thus resulting into higher prices for consumers ultimately driving regional revenue share during the forecast period.
Growth Factors:
- Increasing shrimp production and trade: The global shrimp production is expected to grow at a CAGR of 3.5% from 2016 to 2021, reaching 24.4 million metric tons by 2021. This will create the need for accurate and timely disease diagnosis to maintain the quality of this seafood commodity.
- Rising demand for safe and healthy seafood: The increasing awareness about the health benefits of consuming seafood is driving the demand for safe and healthy shrimps across the globe. This is creating opportunities for growth in the shrimps disease diagnostic market.
- Technological advancements in diagnostics: Rapid technological advancements are taking place in diagnostics, which is aiding in improving accuracy and speed of diagnosis, thus propelling market growth globally . For instance, molecular techniques are being increasingly used for detection of viruses causing diseases in shrimps . Such technological advancements are expected to boost market growth during forecast period . 4) Growing number of aquaculture farms: Aquaculture farming has been gaining popularity as it helps meet rising global demand for seafood products without depleting wild fish stocks.. As a result, there has been an increase in number of shrimp aquaculture farms across regions such as Asia Pacific , North America , Europe , South America etc., which is further fueling demand for shrimps disease diagnostic products/services 5) Stringent food safety regulations: Stringent food safety regulations implemented by governments worldwide are necessitating use of accurate and reliable diagnostic tests/method
Scope Of The Report
Report Attributes
Report Details
Report Title
Shrimps Disease Diagnostic Market Research Report
By Type
WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus), HPV (Hepatopancreatic Parvovirus), MBV (Monodon Baculovirus), IMNV (Infectious Myonecrosis Virus), NHP-B (Necrotising Hepatopancreatitis Bacteria), MoV (Mourilyan Virus), Early Mortality Syndrome (EMS)
By Application
Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others
By Companies
HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, AquaBounty Technologies, Inc, pop bio, SUREBIO, Auro Biotechnologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Shrimps Disease Diagnostic Market Report Segments:
The global Shrimps Disease Diagnostic market is segmented on the basis of:
Types
WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus), HPV (Hepatopancreatic Parvovirus), MBV (Monodon Baculovirus), IMNV (Infectious Myonecrosis Virus), NHP-B (Necrotising Hepatopancreatitis Bacteria), MoV (Mourilyan Virus), Early Mortality Syndrome (EMS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HiMedia Laboratories
- Speedy Assay Sdn Bhd
- REAGEN LLC
- FUJIKURA KASEI CO., LTD
- GeneReach Biotechnology Corp
- Thermo Fisher Scientific
- Lab - Ind Resource Sdn Bhd
- AquaBounty Technologies, Inc
- pop bio
- SUREBIO
- Auro Biotechnologies
Highlights of The Shrimps Disease Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- WSSV (White Spot Syndrome Virus)
- TSV (Taura Syndrome Virus)
- YHV/GAV (Yellow Head/Gill Associated Virus)
- IHHNV (Infectious Hypodermal and Hematopoietic Virus)
- HPV (Hepatopancreatic Parvovirus)
- MBV (Monodon Baculovirus)
- IMNV (Infectious Myonecrosis Virus)
- NHP-B (Necrotising Hepatopancreatitis Bacteria)
- MoV (Mourilyan Virus)
- Early Mortality Syndrome (EMS)
- By Application:
- Fisheries
- Aquaculture Laboratories
- Marine Laboratories
- Education and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Shrimps Disease Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Shrimps disease is a bacterial infection that can be diagnosed through a blood or urine test.
Some of the major companies in the shrimps disease diagnostic market are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, AquaBounty Technologies, Inc, pop bio, SUREBIO, Auro Biotechnologies.
The shrimps disease diagnostic market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Shrimps Disease Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Shrimps Disease Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Shrimps Disease Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Shrimps Disease Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Shrimps Disease Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Shrimps Disease Diagnostic Market Size and Y-o-Y Growth
4.5.2 Shrimps Disease Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Shrimps Disease Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Shrimps Disease Diagnostic Market Size Forecast by Type
5.2.1 WSSV (White Spot Syndrome Virus)
5.2.2 TSV (Taura Syndrome Virus)
5.2.3 YHV/GAV (Yellow Head/Gill Associated Virus)
5.2.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
5.2.5 HPV (Hepatopancreatic Parvovirus)
5.2.6 MBV (Monodon Baculovirus)
5.2.7 IMNV (Infectious Myonecrosis Virus)
5.2.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
5.2.9 MoV (Mourilyan Virus)
5.2.10 Early Mortality Syndrome (EMS)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Shrimps Disease Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Shrimps Disease Diagnostic Market Size Forecast by Applications
6.2.1 Fisheries
6.2.2 Aquaculture Laboratories
6.2.3 Marine Laboratories
6.2.4 Education and Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Shrimps Disease Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Shrimps Disease Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Shrimps Disease Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Shrimps Disease Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Shrimps Disease Diagnostic Market Size Forecast by Type
9.6.1 WSSV (White Spot Syndrome Virus)
9.6.2 TSV (Taura Syndrome Virus)
9.6.3 YHV/GAV (Yellow Head/Gill Associated Virus)
9.6.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
9.6.5 HPV (Hepatopancreatic Parvovirus)
9.6.6 MBV (Monodon Baculovirus)
9.6.7 IMNV (Infectious Myonecrosis Virus)
9.6.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
9.6.9 MoV (Mourilyan Virus)
9.6.10 Early Mortality Syndrome (EMS)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Shrimps Disease Diagnostic Market Size Forecast by Applications
9.10.1 Fisheries
9.10.2 Aquaculture Laboratories
9.10.3 Marine Laboratories
9.10.4 Education and Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Shrimps Disease Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Shrimps Disease Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Shrimps Disease Diagnostic Market Size Forecast by Type
10.6.1 WSSV (White Spot Syndrome Virus)
10.6.2 TSV (Taura Syndrome Virus)
10.6.3 YHV/GAV (Yellow Head/Gill Associated Virus)
10.6.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
10.6.5 HPV (Hepatopancreatic Parvovirus)
10.6.6 MBV (Monodon Baculovirus)
10.6.7 IMNV (Infectious Myonecrosis Virus)
10.6.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
10.6.9 MoV (Mourilyan Virus)
10.6.10 Early Mortality Syndrome (EMS)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Shrimps Disease Diagnostic Market Size Forecast by Applications
10.10.1 Fisheries
10.10.2 Aquaculture Laboratories
10.10.3 Marine Laboratories
10.10.4 Education and Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Shrimps Disease Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Shrimps Disease Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Shrimps Disease Diagnostic Market Size Forecast by Type
11.6.1 WSSV (White Spot Syndrome Virus)
11.6.2 TSV (Taura Syndrome Virus)
11.6.3 YHV/GAV (Yellow Head/Gill Associated Virus)
11.6.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
11.6.5 HPV (Hepatopancreatic Parvovirus)
11.6.6 MBV (Monodon Baculovirus)
11.6.7 IMNV (Infectious Myonecrosis Virus)
11.6.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
11.6.9 MoV (Mourilyan Virus)
11.6.10 Early Mortality Syndrome (EMS)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Shrimps Disease Diagnostic Market Size Forecast by Applications
11.10.1 Fisheries
11.10.2 Aquaculture Laboratories
11.10.3 Marine Laboratories
11.10.4 Education and Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Shrimps Disease Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Shrimps Disease Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Shrimps Disease Diagnostic Market Size Forecast by Type
12.6.1 WSSV (White Spot Syndrome Virus)
12.6.2 TSV (Taura Syndrome Virus)
12.6.3 YHV/GAV (Yellow Head/Gill Associated Virus)
12.6.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
12.6.5 HPV (Hepatopancreatic Parvovirus)
12.6.6 MBV (Monodon Baculovirus)
12.6.7 IMNV (Infectious Myonecrosis Virus)
12.6.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
12.6.9 MoV (Mourilyan Virus)
12.6.10 Early Mortality Syndrome (EMS)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Shrimps Disease Diagnostic Market Size Forecast by Applications
12.10.1 Fisheries
12.10.2 Aquaculture Laboratories
12.10.3 Marine Laboratories
12.10.4 Education and Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Shrimps Disease Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Shrimps Disease Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Shrimps Disease Diagnostic Market Size Forecast by Type
13.6.1 WSSV (White Spot Syndrome Virus)
13.6.2 TSV (Taura Syndrome Virus)
13.6.3 YHV/GAV (Yellow Head/Gill Associated Virus)
13.6.4 IHHNV (Infectious Hypodermal and Hematopoietic Virus)
13.6.5 HPV (Hepatopancreatic Parvovirus)
13.6.6 MBV (Monodon Baculovirus)
13.6.7 IMNV (Infectious Myonecrosis Virus)
13.6.8 NHP-B (Necrotising Hepatopancreatitis Bacteria)
13.6.9 MoV (Mourilyan Virus)
13.6.10 Early Mortality Syndrome (EMS)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Shrimps Disease Diagnostic Market Size Forecast by Applications
13.10.1 Fisheries
13.10.2 Aquaculture Laboratories
13.10.3 Marine Laboratories
13.10.4 Education and Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Shrimps Disease Diagnostic Market: Competitive Dashboard
14.2 Global Shrimps Disease Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 HiMedia Laboratories
14.3.2 Speedy Assay Sdn Bhd
14.3.3 REAGEN LLC
14.3.4 FUJIKURA KASEI CO., LTD
14.3.5 GeneReach Biotechnology Corp
14.3.6 Thermo Fisher Scientific
14.3.7 Lab - Ind Resource Sdn Bhd
14.3.8 AquaBounty Technologies, Inc
14.3.9 pop bio
14.3.10 SUREBIO
14.3.11 Auro Biotechnologies
